Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
214 articles
15 of 22
That weird FDA de-regulatory notice.
3.19.21
6
min. Read
Blues’ verdict on PDTs: No. Pharma digital spin-offs.
3.12.21
7
min. Read
Curious move by BCBSMA on PDTs. Payers talk reimbursement.
3.05.21
7
min. Read
Another Rx DTx quietly launches. Pipeline changes.
2.26.21
6
min. Read
2021 Prescription DTx report. Headspace’s 2020 prediction.
2.19.21
8
min. Read
Sharecare SPAC. Akili strategy. Pear was almost a fund.
2.12.21
8
min. Read
Apple, Pear studies. Bills for DTx Medicaid reimbursement.
2.05.21
6
min. Read
Pear DTC campaign. Happify-Almirall.
1.29.21
7
min. Read
2022: CPT codes for remote therapeutics.
1.22.21
5
min. Read
Breakthrough reimbursement. AliveCor growth. Pear DME.
1.15.21
8
min. Read
1 of 22